Sort
15,842 grants matching “pancreatic cancer”
Inhibition of CDC25B phosphatase by targeting protein-protein interactions
$316,863Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
$316,861Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Rare Exocrine Tumors of the Pancreas
$316,831Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Identification of synthetic lethal interactors in pancreatic cancer
$316,801Channing J Der · Univ Of North Carolina Chapel Hill · U01 · FY2018 · CA
The anti-senescence activity of trefoil factor 1
$316,621Xiao-Fan Wang · Duke University · R01 · FY2016 · CA
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
$316,600Jonathan Maybaum · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
A novel molecular cross-talk driving pancreatic cancer progression
$316,557Ajay Pratap Singh · University Of South Alabama · R01 · FY2020 · CA
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
$316,555Amy E Wright · Florida Atlantic University · R01 · FY2012 · CA
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
$316,555Amy E Wright · Florida Atlantic University · R01 · FY2011 · CA
Role of TGFBeta alterations in pancreatic cancer
$316,496James Freeman · University Of Texas Hlth Science Center · R01 · FY2014 · CA
SAMBAI - Bridging Research Investigations of cancer Disparities and Global Equity (BRIDGE)
$316,465Lauren E McCullough · Emory University · OT2 · FY2024 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$316,438Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2020 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2017 · CA
OPTIMIZING RADIATION THERAPY THROUGH MANIPULATION OF TUMOR GLUCOSE METABOLISM
$316,438Julie Kristina Schwarz · Washington University · R01 · FY2017 · CA
Project 2: Biological Effects of Patient-derived Mutations in MUC16 on PC Metastasis
$316,438Michael A Hollingsworth · University Of Nebraska Medical Center · P01 · FY2021 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2015 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2016 · CA
REPROGRAMMING THE METASTATIC MICROENVIRONMENT OF PANCREATIC CANCER THROUGH CSF1R
$316,438David G Denardo · Washington University · R01 · FY2018 · CA
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
$316,437Pankaj Kumar Singh · University Of Nebraska Medical Center · P01 · FY2020 · CA
Project 3: MUC16-Mediated Metabolic Reprograming Induces PC Metastasis
$316,437Pankaj Kumar Singh · University Of Nebraska Medical Center · P01 · FY2021 · CA
Neuropeptide Regulation of Enteropancreatic Function
$316,403Michael W. Mulholland · University Of Michigan At Ann Arbor · R37 · FY2007 · DK
Role of Neuropillins in Pancreatic Cancer
$316,395Dartmouth College · R01 · FY2005 · CA
Role of Neuropillins in Pancreatic Cancer
$316,395Dartmouth College · R01 · FY2004 · CA
Role of Neuropillins in Pancreatic Cancer
$316,395Dartmouth College · R01 · FY2003 · CA
Core B â Human Biospecimen and Advanced Sequencing Core
$316,362Leonidas G Koniaris · Medical University Of South Carolina · P01 · FY2022 · CA